Cytosorbents CorporationCTSONASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-49.16%
↑ 31% vs avg
Percentile
P80
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-71.35%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -49.16% | -15.0% |
| 2024 | -42.75% | +52.3% |
| 2023 | -89.69% | -3.7% |
| 2022 | -86.49% | -60.5% |
| 2021 | -53.89% | -119.0% |
| 2020 | -24.61% | +70.1% |
| 2019 | -82.33% | -4.3% |
| 2018 | -78.90% | -29.2% |
| 2017 | -61.05% | +57.8% |
| 2016 | -144.58% | - |